Literature DB >> 23785200

Primary human leukocyte subsets differentially express vaccinia virus receptors enriched in lipid rafts.

Daniel Byrd1, Tohti Amet, Ningjie Hu, Jie Lan, Sishun Hu, Qigui Yu.   

Abstract

Poxviruses, including vaccinia virus (VV) and canarypox virus (ALVAC), do not indiscriminately infect all cell types of the primary human leukocytes (PHLs) that they encounter but instead demonstrate an extremely strong bias toward infection of monocytes and monocyte lineage cells. We studied the specific molecular events that determine the VV tropism for major PHL subsets including monocytes, B cells, neutrophils, NK cells, and T cells. We found that VV exhibited an extremely strong bias of cell surface protein-dependent binding to monocytes, B cells, and activated T cells to a similar degree and to neutrophils to a much lesser extent. Resting T cells and resting NK cells exhibited only trace amounts of VV binding. Activated T cells, however, became permissive to VV binding, infection, and replication, while activated NK cells still resisted VV binding. VV binding strongly colocalized with lipid rafts on the surfaces of all VV binding-susceptible PHL subsets, even when lipid rafts were relocated to cell uropods upon cell polarization. Immunosera raised against detergent-resistant membranes (DRMs) from monocytes or activated T cells, but not resting T cells, effectively cross-blocked VV binding to and infection of PHL subsets. CD29 and CD98, two lipid raft-associated membrane proteins that had been found to be important for VV entry into HeLa cells, had no effect on VV binding to and infection of primary activated T cells. Our data indicate that PHL subsets express VV protein receptors enriched in lipid rafts and that receptors are cross-presented on all susceptible PHLs.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23785200      PMCID: PMC3754057          DOI: 10.1128/JVI.01545-13

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  45 in total

1.  Segregation of leading-edge and uropod components into specific lipid rafts during T cell polarization.

Authors:  C Gómez-Móuton; J L Abad; E Mira; R A Lacalle; E Gallardo; S Jiménez-Baranda; I Illa; A Bernad; S Mañes; C Martínez-A
Journal:  Proc Natl Acad Sci U S A       Date:  2001-08-07       Impact factor: 11.205

Review 2.  Studying the binding and entry of the intracellular and extracellular enveloped forms of vaccinia virus.

Authors:  Mansun Law; Geoffrey L Smith
Journal:  Methods Mol Biol       Date:  2004

3.  Monocyte lipid rafts contain proteins implicated in vesicular trafficking and phagosome formation.

Authors:  Nan Li; Allan Mak; Dawn P Richards; Claudia Naber; Bernd O Keller; Liang Li; Andrew R E Shaw
Journal:  Proteomics       Date:  2003-04       Impact factor: 3.984

4.  AILIM/ICOS signaling induces T-cell migration/polarization of memory/effector T-cells.

Authors:  Naokazu Okamoto; Yuko Nukada; Katsunari Tezuka; Kazumasa Ohashi; Kensaku Mizuno; Takashi Tsuji
Journal:  Int Immunol       Date:  2004-08-31       Impact factor: 4.823

5.  General method for production and selection of infectious vaccinia virus recombinants expressing foreign genes.

Authors:  M Mackett; G L Smith; B Moss
Journal:  J Virol       Date:  1984-03       Impact factor: 5.103

6.  Unbiased quantitative proteomics of lipid rafts reveals high specificity for signaling factors.

Authors:  Leonard J Foster; Carmen L De Hoog; Matthias Mann
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-30       Impact factor: 11.205

7.  Lipid raft-associated protein sorting in exosomes.

Authors:  Aude de Gassart; Charles Geminard; Benoit Fevrier; Graca Raposo; Michel Vidal
Journal:  Blood       Date:  2003-07-24       Impact factor: 22.113

8.  Exploring the potential of variola virus infection of cynomolgus macaques as a model for human smallpox.

Authors:  Peter B Jahrling; Lisa E Hensley; Mark J Martinez; James W Leduc; Kathleen H Rubins; David A Relman; John W Huggins
Journal:  Proc Natl Acad Sci U S A       Date:  2004-10-11       Impact factor: 11.205

9.  Oncolytic vaccinia virus disrupts tumor-associated vasculature in humans.

Authors:  Caroline J Breitbach; Rozanne Arulanandam; Naomi De Silva; Steve H Thorne; Richard Patt; Manijeh Daneshmand; Anne Moon; Carolina Ilkow; James Burke; Tae-Ho Hwang; Jeong Heo; Mong Cho; Hannah Chen; Fernando A Angarita; Christina Addison; J Andrea McCart; John C Bell; David H Kirn
Journal:  Cancer Res       Date:  2013-02-07       Impact factor: 12.701

10.  Vaccinia virus A28L gene encodes an essential protein component of the virion membrane with intramolecular disulfide bonds formed by the viral cytoplasmic redox pathway.

Authors:  Tatiana G Senkevich; Brian M Ward; Bernard Moss
Journal:  J Virol       Date:  2004-03       Impact factor: 5.103

View more
  11 in total

1.  The canarypox virus vector ALVAC induces distinct cytokine responses compared to the vaccinia virus-based vectors MVA and NYVAC in rhesus monkeys.

Authors:  Jeffrey E Teigler; Sanjay Phogat; Genoveffa Franchini; Vanessa M Hirsch; Nelson L Michael; Dan H Barouch
Journal:  J Virol       Date:  2013-11-20       Impact factor: 5.103

2.  Primary Human B Cells at Different Differentiation and Maturation Stages Exhibit Distinct Susceptibilities to Vaccinia Virus Binding and Infection.

Authors:  Nicole Shepherd; Jie Lan; Wei Li; Sushmita Rane; Qigui Yu
Journal:  J Virol       Date:  2019-09-12       Impact factor: 5.103

3.  Provirus activation plus CD59 blockage triggers antibody-dependent complement-mediated lysis of latently HIV-1-infected cells.

Authors:  Jie Lan; Kai Yang; Daniel Byrd; Ningjie Hu; Tohti Amet; Nicole Shepherd; Mona Desai; Jimin Gao; Samir Gupta; Yongtao Sun; Qigui Yu
Journal:  J Immunol       Date:  2014-08-22       Impact factor: 5.422

4.  Glycosylphosphatidylinositol Anchor Deficiency Attenuates the Production of Infectious HIV-1 and Renders Virions Sensitive to Complement Attack.

Authors:  Tohti Amet; Jie Lan; Nicole Shepherd; Kai Yang; Daniel Byrd; Yanyan Xing; Qigui Yu
Journal:  AIDS Res Hum Retroviruses       Date:  2016-07-27       Impact factor: 2.205

5.  Blockage of CD59 Function Restores Activities of Neutralizing and Nonneutralizing Antibodies in Triggering Antibody-Dependent Complement-Mediated Lysis of HIV-1 Virions and Provirus-Activated Latently Infected Cells.

Authors:  Kai Yang; Jie Lan; Nicole Shepherd; Ningjie Hu; Yanyan Xing; Daniel Byrd; Tohti Amet; Corlin Jewell; Samir Gupta; Carole Kounga; Jimin Gao; Qigui Yu
Journal:  J Virol       Date:  2015-07-01       Impact factor: 5.103

6.  Cofilin, an intracellular marker for HIV-associated CD4 T-cell motility dysregulation, shed light on the mechanisms of incomplete immune reconstitution in the patients with HIV.

Authors:  Fahim Syed; Qigui Yu
Journal:  J Med Virol       Date:  2019-09-09       Impact factor: 2.327

7.  Primary human macrophages serve as vehicles for vaccinia virus replication and dissemination.

Authors:  Daniel Byrd; Nicole Shepherd; Jie Lan; Ningjie Hu; Tohti Amet; Kai Yang; Mona Desai; Qigui Yu
Journal:  J Virol       Date:  2014-04-02       Impact factor: 5.103

8.  Oncolytic virus efficiency inhibited growth of tumour cells with multiple drug resistant phenotype in vivo and in vitro.

Authors:  Elena P Goncharova; Julia S Ruzhenkova; Ivan S Petrov; Sergey N Shchelkunov; Marina A Zenkova
Journal:  J Transl Med       Date:  2016-08-18       Impact factor: 5.531

Review 9.  Oncolytic Virotherapy with Myxoma Virus.

Authors:  Masmudur M Rahman; Grant McFadden
Journal:  J Clin Med       Date:  2020-01-08       Impact factor: 4.241

Review 10.  A comparative review of viral entry and attachment during large and giant dsDNA virus infections.

Authors:  Haitham Sobhy
Journal:  Arch Virol       Date:  2017-09-02       Impact factor: 2.574

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.